Co-Founder & CEO of bioaccess® · CEO of Synapse Global Theranostics
With over two decades of cross-industry leadership spanning healthcare, telecommunications, and venture capital, Julio Martinez-Clark has become a trusted partner for 100+ companies seeking accelerated regulatory approvals and cost-effective clinical trials worldwide.
He co-founded bioaccess® in 2010 as the First-in-Human CRO — purpose-built for First-in-Human and Early Feasibility Studies across the U.S. and Latin America. His fusion of technical expertise, regulatory acumen, and operational mastery positions him as a definitive authority on medical innovation in emerging markets.
Julio is the founder of the Global Trial Accelerators podcast and is a contributing writer for Med Device Online with 25+ published articles covering clinical trials, regulatory strategy, and medical innovation in emerging markets.